Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(5-(4-amino-3-oxido-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl)-methyl dihydrogen phosphate
i.e. CMP-N3-oxide
2'-deoxy-2'-fluoro-6-iodo-beta-D-uridine 5'-O-monophosphate
-
-
2'-deoxy-2'-fluoro-6-iodo-UMP
-
-
2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl-cytosine
-
-
5-cyano-2'-deoxy-2'-fluoro-beta-D-uridine 5'-O-monophosphate
-
-
5-cyano-UMP
-
poor inhibition
6-amido-2'-deoxy-2'-fluoro-beta-D-uridine 5'-O-monophosphate
-
poor inhibitor
6-amino-5-fluorouridine
-
competitive inhibition at submicromolar concentrations
6-aminouridine 5'-monophosphate
-
-
6-azauridine
-
potent inhibitor
6-azauridine 5'-monophosphate
-
-
6-azido-2'-deoxy-2'-fluoro-beta-D-uridine 5'-O-monophosphate
-
-
6-azido-5-fluorouridine
-
irreversible inhibitor
6-azidouridine 5'-monophosphate
-
-
6-cyano-2'-deoxy-2'-fluoro-beta-D-uridine 5'-O-monophosphate
-
reversible inhibitor
6-cyanouridine 5'-monophosphate
-
-
6-hydroxyuridine
-
potent inhibitor
6-iodouridine 5'-monophosphate
-
-
6-thiocarboxamidouridine
-
potent inhibitor
6-thiocarboxamidouridine 5'-monophosphate
-
-
barbiturate ribonucleoside 5'-monophosphate
-
very potent inhibitor
barbituric acid ribonucleoside 5'-monophosphate
-
-
beta-D-ribofuranosylbarbiturate 5'-monophosphate
-
potent inhibitor
pyrazofurin 5'-monophosphate
-
-
pyrazofurin-5'-monophosphate
-
slow tight binding inhibitor
Xanthosine
-
potent inhibitor
xanthosine 5'-monophosphate
-
-
nifedipine
-
competitive inhibition
nifedipine
-
competitive inhibitor
nimodipine
-
competitive inhibition
nimodipine
-
competitive inhibitor
pyrazofurin
-
potent inhibitor
pyrazofurin
-
also known as pyrazomycin, potent inhibitor
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Anemia, Hypoplastic, Congenital
Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.
Aspergillosis
Attenuated virulence of uridine-uracil auxotrophs of Aspergillus fumigatus.
Candidiasis
Evaluation of the roles of four Candida albicans genes in virulence by using gene disruption strains that express URA3 from the native locus.
Carcinoma
Isolation and initial characterization of the single polypeptide that synthesizes uridine 5'-monophosphate from orotate in Ehrlich ascites carcinoma. Purification by tandem affinity chromatography of uridine-5'-monophosphate synthase.
Carcinoma
Potential for ambiguity in the interpretation of immunochemical studies on multienzymic proteins. The case of uridylate synthase.
Carcinoma
Purification, size, and properties of the complex of orotate phosphoribosyltransferase: orotidylate decarboxylase from mouse Ehrlich ascites carcinoma.
Carcinoma
The purification and preliminary characterization of UMP synthase from human placenta.
Carcinoma, Hepatocellular
Amplification of the UMP synthase gene and enzyme overproduction in pyrazofurin-resistant rat hepatoma cells. Molecular cloning of a cDNA for UMP synthase.
Carcinoma, Hepatocellular
Increased levels of UMP synthase protein and mRNA in pyrazofurin-resistant rat hepatoma cells.
Carcinoma, Hepatocellular
Orotate phosphoribosyl transferase and orotidylic acid decarboxylase activities in liver and Morris hepatomas.
Carcinoma, Hepatocellular
Potentiation of antimetabolite action by dibromodulcitol in cell culture.
Communicable Diseases
Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kinetics.
Communicable Diseases
Inhibition of orotidine 5'-monophosphate decarboxylase and its therapeutic potential.
Cysts
Nonreplicating, cyst-defective type II Toxoplasma gondii vaccine strains stimulate protective immunity against acute and chronic infection.
Hepatitis B
Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives.
Herpes Simplex
Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives.
HIV Infections
Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives.
Infections
Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives.
Leukemia
Studies on a pyrimidine phosphoribosyltransferase from murine leukemia P1534J. Partial purification, substrate specificity, and evidence for its existence as a bifunctional complex with orotidine 5-phosphate decarboxylase.
Lymphoma
Pyrimidine pathway variants of cultured mouse lymphoma cells with altered levels of both orotate phosphoribosyltransferase and orotidylate decarboxylase.
Malaria
A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization.
Malaria
A potent, covalent inhibitor of orotidine 5'-monophosphate decarboxylase with antimalarial activity.
Malaria
A unique insertion of low complexity amino acid sequence underlies protein-protein interaction in human malaria parasite orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase.
Malaria
Crystallization and preliminary crystallographic analysis of orotidine 5'-monophosphate decarboxylase from the human malaria parasite Plasmodium falciparum.
Malaria
Design of inhibitors of ODCase.
Malaria
Inhibition of orotidine 5'-monophosphate decarboxylase and its therapeutic potential.
Malaria
Insights into the pyrimidine biosynthetic pathway of human malaria parasite Plasmodium falciparum as chemotherapeutic target.
Malaria
Kinetic benefits and thermal stability of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase enzyme complex in human malaria parasite Plasmodium falciparum.
Malaria
Novel cytidine-based orotidine-5'-monophosphate decarboxylase inhibitors with an unusual twist.
Malaria
Orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase exist as multienzyme complex in human malaria parasite Plasmodium falciparum.
Mycosis Fungoides
Clinical trial of weekly pyrazofurin.
Neoplasm Metastasis
Hypoxia enhances aggressiveness of cholangiocarcinoma cells.
Neoplasms
Enzymes of the de novo and salvage pathways for pyrimidine biosynthesis in normal colon, colon carcinoma, and xenografts.
Neoplasms
Inhibition of orotidine 5'-monophosphate decarboxylase and its therapeutic potential.
Neoplasms
Structures of the human orotidine-5'-monophosphate decarboxylase support a covalent mechanism and provide a framework for drug design.
ornithine carbamoyltransferase deficiency
Activity of orotate metabolizing enzyme complex and various urea-cycle enzymes in mutant mice with ornithine transcarbamylase deficiency.
Ornithine Carbamoyltransferase Deficiency Disease
Activity of orotate metabolizing enzyme complex and various urea-cycle enzymes in mutant mice with ornithine transcarbamylase deficiency.
orotidine-5'-phosphate decarboxylase deficiency
Consequences of UMP synthase deficiency in cattle.
orotidine-5'-phosphate decarboxylase deficiency
Deficiency of UMP synthase in dairy cattle: a model for hereditary orotic aciduria.
orotidine-5'-phosphate decarboxylase deficiency
Detection and prevalence of UMP synthase deficiency among dairy cattle.
orotidine-5'-phosphate decarboxylase deficiency
Molecular cloning of the human UMP synthase gene and characterization of point mutations in two hereditary orotic aciduria families.
pantoate-beta-alanine ligase (amp-forming) deficiency
Disorders of purine and pyrimidine metabolism.
Parasitic Diseases
Design of inhibitors of ODCase.
Parasitic Diseases
Inhibition of orotidine 5'-monophosphate decarboxylase and its therapeutic potential.
Persistent Infection
Nonreplicating, cyst-defective type II Toxoplasma gondii vaccine strains stimulate protective immunity against acute and chronic infection.
Polycythemia Vera
Clinical trial of weekly pyrazofurin.
Poxviridae Infections
Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectives.
Psoriasis
Clinical trial of weekly pyrazofurin.
Sarcoma, Avian
Activation of ornithine decarboxylase in monolayer cells treated with trypsin.
Smallpox
Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectives.
Starvation
Cloning and characterization of the pyrF operon of Salmonella typhimurium.
Starvation
Effects of phosphate limitation on expression of genes involved in pyrimidine synthesis and salvaging in Arabidopsis.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.028
(5-(4-amino-3-oxido-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl)-methyl dihydrogen phosphate
pH 7.5, 22°C
0.759
5-cyano-2'-deoxy-2'-fluoro-beta-D-uridine 5'-O-monophosphate
-
in 50 mM Tris, pH 7.5, 20 mM dithiothreitol, and 40 mM NaCl, at 55°C
4
6-amido-2'-deoxy-2'-fluoro-beta-D-uridine 5'-O-monophosphate
-
Ki above 4 mM, in 50 mM Tris, pH 7.5, 20 mM dithiothreitol, and 40 mM NaCl, at 55°C
2
6-cyano-2'-deoxy-2'-fluoro-beta-D-uridine 5'-O-monophosphate
-
Ki above 2 mM, in 50 mM Tris, pH 7.5, 20 mM dithiothreitol, and 40 mM NaCl, at 55°C
0.204
6-cyanouridine
-
in 50 mM Tris, pH 7.5, 20 mM dithiothreitol, and 40 mM NaCl, at 55°C
0.000017
pyrazofurin-5'-monophosphate
-
in 50 mM Tris (pH 7.5), 20 mM dithiothreitol, and 40 mM NaCl, at 22°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
crystal structure in complex with inhibitor (5-(4-amino-3-oxido-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl)-methyl dihydrogen phosphate. Compared to cytosin, the pyrimidine portion exhibits changes in the atomic arrangement. The oxygen atom migrates from N3 to N4 or the C5 position of the cytosine ring. These rearranged nucleotides are each bound to the enzyme in a 2?-endo,syn conformation
nine crystal structures of human OMPD in complex with substrate, product and nucleotide inhibitors are described
purified detagged recombinant enzyme, 5 mg/ml protein in 20 mM HEPES-NaOH, pH 7.4, sitting-drop setup, mixing with 0.1 M Tris-HCl, pH 8.0, and 1.8 M (NH4)2SO4 in a 1:1 ratio at 22°C, cryoprotection with 20%v/v glycerol in mother liquor, X-ray diffraction structure determination and analysis at 1.85-1.92 A resolution, molecular replacement using data from a highly twinned monoclinic crystal, pseudo-merohedrally twinned crystals, overview
hanging drop vapor diffusion method
-
hanging drop vapor diffusion method, using 100 mM Tris-HCl, pH 8.4, 2.12 M ammonium sulfate (enzyme in complex with barbiturate ribonucleoside-5'-monophosphate and 1-(5-monophosphoryl-beta-D-ribofuranos-1-yl)-5-cyanouracil) or using 100 mM Tris-HCl, pH 8.4, 1.4 M ammonium sulfate (enzyme in complex with pyrazofurin-5'-monophosphate)
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Brown, G.K.; Fox, R.M.; O'Sullivan, W.J.
Interconversion of different molecular weight forms of human erythrocyte orotidylate decarboxylase
J. Biol. Chem.
250
7352-7358
1975
Homo sapiens
brenda
Jones, M.E.
Orotidylate decarboxylase of yeast and man
Curr. Top. Cell. Regul.
33
331-342
1992
Saccharomyces cerevisiae, Homo sapiens, Mus musculus
brenda
Yablonski, M.J.; Pasek, D.A.; Han, B.D.; Jones, M.E.; Traut, T.W.
Intrinsic activity and stability of bifunctional human UMP synthase and its two separate catalytic domains, orotate phosphoribosyltransferase and orotidine-5'-phosphate decarboxylase
J. Biol. Chem.
271
10704-10708
1996
Homo sapiens
brenda
Wittmann, J.G.; Rudolph, M.G.
Pseudo-merohedral twinning in monoclinic crystals of human orotidine-5-monophosphate decarboxylase
Acta Crystallogr. Sect. D
63
744-749
2007
Homo sapiens (P11172), Homo sapiens
brenda
Poduch, E.; Wei, L.; Pai, E.F.; Kotra, L.P.
Structural diversity and plasticity associated with nucleotides targeting orotidine monophosphate decarboxylase
J. Med. Chem.
51
432-438
2008
Homo sapiens, Methanothermobacter thermautotrophicus (O26232), Methanothermobacter thermautotrophicus, Plasmodium falciparum (Q8IJH3), Plasmodium falciparum
brenda
Meza-Avina, M.E.; Wei, L.; Buhendwa, M.G.; Poduch, E.; Bello, A.M.; Pai, E.F.; Kotra, L.P.
Inhibition of orotidine 5-monophosphate decarboxylase and its therapeutic potential
Mini Rev. Med. Chem.
8
239-247
2008
Bacillus subtilis, Saccharomyces cerevisiae, Escherichia coli, Homo sapiens, Plasmodium falciparum, Plasmodium vivax, Methanococcus thermoautotrophicum
brenda
Kotra, L.P.; Pai, E.F.
Inhibition of orotidine-5-monophosphate decarboxylase--discoveries and lessons
Nucleic Acids Symp. Ser.
52
85-86
2008
Helicobacter pylori, Homo sapiens, Staphylococcus aureus, Plasmodium falciparum, Methanothermobacter thermautotrophicus (O26232)
brenda
Wittmann, J.G.; Heinrich, D.; Gasow, K.; Frey, A.; Diederichsen, U.; Rudolph, M.G.
Structures of the human orotidine-5-monophosphate decarboxylase support a covalent mechanism and provide a framework for drug design
Structure
16
82-92
2008
Homo sapiens (P11172), Homo sapiens
brenda
Meza-Avina, M.E.; Wei, L.; Liu, Y.; Poduch, E.; Bello, A.M.; Mishra, R.K.; Pai, E.F.; Kotra, L.P.
Structural determinants for the inhibitory ligands of orotidine-5'-monophosphate decarboxylase
Bioorg. Med. Chem.
18
4032-4041
2010
Saccharomyces cerevisiae, Helicobacter pylori, Homo sapiens, Methanothermobacter thermautotrophicus, Staphylococcus aureus, Plasmodium falciparum
brenda
Lewis, M.; Meza-Avina, M.E.; Wei, L.; Crandall, I.E.; Bello, A.M.; Poduch, E.; Liu, Y.; Paige, C.J.; Kain, K.C.; Pai, E.F.; Kotra, L.P.
Novel interactions of fluorinated nucleotide derivatives targeting orotidine 5'-monophosphate decarboxylase
J. Med. Chem.
54
2891-2901
2011
Homo sapiens, Methanothermobacter thermautotrophicus
brenda
Huang, S.; Wong, F.M.; Gassner, G.T.; Wu, W.
Accelerated hydrolysis of alpha-halo and alpha-cyano pyridinium relative to uracil derivatives: a model for ODCase-catalyzed hydrolysis of 6-cyanoUMP
Tetrahedron Lett.
52
3960-3962
2011
Homo sapiens
brenda
Purohit, M.K.; Poduch, E.; Wei, L.W.; Crandall, I.E.; To, T.; Kain, K.C.; Pai, E.F.; Kotra, L.P.
Novel cytidine-based orotidine-5-monophosphate decarboxylase inhibitors with an unusual twist
J. Med. Chem.
55
9988-9997
2012
Homo sapiens (P11172), Plasmodium falciparum (Q8IJH3), Plasmodium falciparum
brenda